Eric Pauwels, CHIEF BUSINESS OFFICER at PTC THERAPEUTICS, INC. (PTCT), sold 86,313 shares at $75.28 ($6.5M) on 2025-12-17, disclosed to the SEC on 2025-12-19.
Scheduled sale ($6.5M) by CHIEF BUSINESS OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.28 | 1,245 | $94K | 1.4% |
| 2 | $75.28 | 1,245 | $94K | 1.4% |
| 3 | $75.31 | 3,584 | $270K | 4.1% |
| 4 | $75.31 | 3,584 | $270K | 4.1% |
| 5 | $75.44 | 35,261 | $2.7M | 40.9% |
| 6 | $75.44 | 35,261 |
| $2.7M |
| 40.9% |
| 7 | $76.00 | 100 | $8K | 0.1% |
| 8 | $75.00 | 251 | $19K | 0.3% |
| 9 | $75.02 | 120 | $9K | 0.1% |
| 10 | $75.07 | 2,831 | $213K | 3.3% |
| 11 | $75.07 | 2,831 | $213K | 3.3% |
| Total | $75.40 avg | 86,313 | $6.5M | 100% |
| Filing → |
| PTCT | SELL | 2026-01-12 | $566K | — | Filing → |
| PTCT | SELL | 2026-01-08 | $242K | — | Filing → |
| PTCT | SELL | 2025-12-23 | $3.0M | — | Filing → |